Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seamaty is a China-based in vitro diagnostics and medical device company focused on point-of-care testing for human and veterinary applications. Founded in 2012 and headquartered in Chengdu, the company develops, manufactures, and sells diagnostic analyzers and reagent consumables spanning biochemistry, chemiluminescence immunoassay, blood gas and electrolyte, and hematology testing. Its product portfolio includes dry chemistry analyzers, fully automated chemistry systems, blood gas analyzers, hematology analyzers, and associated reagent discs for decentralized testing settings. Seamaty appears to operate as a commercial-stage diagnostics manufacturer rather than a therapeutic drug developer, with international distribution across more than 100 countries and regions and a growing manufacturing footprint in China and overseas subsidiaries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Seamaty Technology.